TrialSignal
Clinical trial intelligence report
Is E2 Luteal Support in High Responder Long Gn-RH Agonist ICSI Cycles Detrimental to Cycle Outcome ? A Randomized Clinical Trial
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT01790282
Status
COMPLETED
Phase
NA
Sponsor
Mansoura Integrated Fertility Center
Executive brief
Investment-Ready Snapshot
This clinical trial investigates the impact of adding estradiol (E2) to progesterone (P4) for luteal phase support in high ovarian responders undergoing ICSI. The study aims to clarify conflicting evidence regarding the efficacy of E2 in improving pregnancy outcomes.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT01790282
Indication
IVF
Modality
small molecule
Target
Luteal phase support in high responder ICSI cycles
Intervention
estradiol plus progesterone 100 mg IM injection, Progesterone IM of 100 mg
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.